Fingerprint
Dive into the research topics where Sayed Hashemi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib
Zwierenga, F., Muntinghe-Wagenaar, M. B., Rozendal, P., de Langen, A. J., Hendriks, L. E. L., van den Heuvel, M., van der Leest, C., Hashemi, S. M. S., van der Leest, P., Hiltermann, T. J. N., Schuuring, E. & van der Wekken, A. J., Jul 2025, In: Targeted oncology. 20, 4, p. 663-677 15 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile40 Downloads (Pure) -
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
Rakaee, M., Tafavvoghi, M., Ricciuti, B., Alessi, J. V., Cortellini, A., Citarella, F., Nibid, L., Perrone, G., Adib, E., Fulgenzi, C. A. M., Hidalgo Filho, C. M., Di Federico, A., Jabar, F., Hashemi, S., Houda, I., Richardsen, E., Rasmussen Busund, L. T., Donnem, T., Bahce, I. & Pinato, D. J. & 4 others, , 20 Feb 2025, In: JAMA oncology. 11, 2, p. 109-118 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile58 Downloads (Pure) -
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
van der Wel, J. W. T., Ernst, S. M., Jebbink, M., van den Broek, D., Badrising, S. K., Steinbusch, L. C., Ruiter, G., Theelen, W. S. M. E., van Veggel, B. A. M. H., Smit, J., Dingemans, A. M., Paats, M. S., Dubbink, H. J., Hashemi, S. M. S., Radonic, T., Cohen, D., van der Wekken, A. J., ter Elst, A., Timens, W. & Hendriks, L. E. & 9 others, , 1 Nov 2025, In: Lung Cancer. 209, 108783.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Downloads (Pure) -
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort
van der Wel, J. W. T., Jebbink, M., van den Broek, D., Steinbusch, L. C., Theelen, W. S. M. E., Ruiter, G., Buikhuisen, W., Burgers, J. A., Baas, P., Vermeulen, M., van der Noort, V., Hashemi, S. M. S., Bosch, L. J. W., Monkhorst, K., Smit, E. F., Boelens, M. C. & de Langen, A. J., 1 Dec 2024, In: Lung Cancer. 198, 107972.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile46 Downloads (Pure) -
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET
Pouw, J. E. E., Hashemi, S. M. S., Huisman, M. C., Wijngaarden, J. E., Slebe, M., Oprea-Lager, D. E., Zwezerijnen, G. J. C., Vugts, D., Ulas, E. B., de Gruijl, T. D., Radonic, T., Senan, S., Menke-van der Houven van Oordt, C. W. & Bahce, I., 1 Feb 2024, In: Journal for immunotherapy of cancer. 12, 2, e007659.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile54 Downloads (Pure)